Pharmacological Differences Between Botulinum Toxin Type A 900 kDa Complex and 150 kDa Neurotoxin Protein

Toxicon 2026

View at publisher

Authors: Ron S. Broide, Greg Nicholson, Michelle Cano, D P Canty, Terry Boodhoo, Amy D. Brideau-Andersen, Mitchell F. Brin

DOI: 10.1016/j.toxicon.2025.108706

Cited by: 0

Fields of Study & Subjects

Botulinum Toxin and Related Neurological Disorders Neurological disorders and treatments Trigeminal Neuralgia and Treatments